Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

β-hydroxy-β-methylbutyrate (HMB) Pilot Feasibility and Efficacy Study in Cerebral Palsy (CP)

NCT05384951 is registered in ClinicalTrials.gov with Gillette Children's Specialty Healthcare as lead sponsor.

NCT NCT05384951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05384951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
β-hydroxy-β-methylbutyrate (HMB) Pilot Feasibility and Efficacy Study in Cerebral Palsy (CP)
Lead sponsor
Gillette Children's Specialty Healthcare
Phase
Not applicable
Overall status
Unknown status
Start date
May 15, 2022
Completion date
May 31, 2024
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy